Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | EYEN |
---|---|---|
09:32 ET | 460 | 0.7739 |
09:38 ET | 1287 | 0.7511 |
09:43 ET | 901 | 0.76 |
09:45 ET | 818 | 0.7502 |
09:59 ET | 2200 | 0.76005 |
10:01 ET | 270 | 0.751 |
10:06 ET | 200 | 0.7502 |
10:14 ET | 100 | 0.75555 |
10:15 ET | 100 | 0.7556 |
10:21 ET | 600 | 0.7603 |
10:26 ET | 600 | 0.7653 |
10:32 ET | 100 | 0.7653 |
10:33 ET | 2745 | 0.7693 |
10:35 ET | 530 | 0.7606 |
10:37 ET | 100 | 0.7653 |
10:39 ET | 500 | 0.7653 |
10:44 ET | 10914 | 0.7735 |
10:46 ET | 600 | 0.77065 |
10:48 ET | 700 | 0.76975 |
10:51 ET | 100 | 0.76975 |
10:53 ET | 100 | 0.76975 |
10:55 ET | 1200 | 0.7687 |
11:02 ET | 100 | 0.76635 |
11:04 ET | 1421 | 0.76635 |
11:06 ET | 100 | 0.76635 |
11:08 ET | 3700 | 0.77065 |
11:09 ET | 3447 | 0.7794 |
11:11 ET | 3613 | 0.7736 |
11:15 ET | 3864 | 0.77395 |
11:18 ET | 7162 | 0.77385 |
11:31 ET | 571 | 0.761 |
11:33 ET | 100 | 0.7611 |
11:38 ET | 200 | 0.7652 |
11:40 ET | 200 | 0.7652 |
11:42 ET | 3339 | 0.7695 |
11:44 ET | 100 | 0.7651 |
11:45 ET | 400 | 0.7652 |
11:47 ET | 1100 | 0.7694 |
11:49 ET | 100 | 0.7651 |
11:51 ET | 100 | 0.7653 |
11:54 ET | 1609 | 0.776 |
11:56 ET | 100 | 0.7644 |
11:58 ET | 3652 | 0.7712 |
12:05 ET | 100 | 0.765 |
12:07 ET | 100 | 0.7643 |
12:09 ET | 3000 | 0.776207 |
12:12 ET | 400 | 0.76985 |
12:16 ET | 600 | 0.7617 |
12:18 ET | 2888 | 0.76985 |
12:20 ET | 900 | 0.77 |
12:25 ET | 200 | 0.769 |
12:27 ET | 200 | 0.7712 |
12:30 ET | 100 | 0.762 |
12:36 ET | 200 | 0.7622 |
12:38 ET | 100 | 0.7622 |
12:39 ET | 300 | 0.7621 |
12:41 ET | 240 | 0.7621 |
12:43 ET | 1238 | 0.7621 |
12:45 ET | 2198 | 0.77 |
12:48 ET | 200 | 0.7621 |
12:50 ET | 3710 | 0.76605 |
12:52 ET | 400 | 0.76605 |
12:54 ET | 100 | 0.76605 |
12:56 ET | 1705 | 0.7697 |
12:57 ET | 100 | 0.76865 |
12:59 ET | 320 | 0.7673 |
01:03 ET | 326 | 0.77 |
01:06 ET | 1100 | 0.7684 |
01:08 ET | 3600 | 0.7753 |
01:19 ET | 100 | 0.7697 |
01:21 ET | 200 | 0.7697 |
01:28 ET | 10546 | 0.77 |
01:30 ET | 400 | 0.76855 |
01:33 ET | 5200 | 0.76705 |
01:35 ET | 1239 | 0.768 |
01:37 ET | 300 | 0.7686 |
01:39 ET | 200 | 0.7686 |
01:44 ET | 300 | 0.7691 |
01:46 ET | 3558 | 0.76885 |
01:48 ET | 500 | 0.7682 |
01:50 ET | 100 | 0.76885 |
01:51 ET | 200 | 0.7696 |
01:53 ET | 100 | 0.76885 |
01:57 ET | 100 | 0.7685 |
02:00 ET | 400 | 0.769 |
02:04 ET | 200 | 0.76935 |
02:11 ET | 6110 | 0.7694 |
02:15 ET | 3200 | 0.7681 |
02:18 ET | 3711 | 0.76875 |
02:20 ET | 200 | 0.7681 |
02:22 ET | 100 | 0.768 |
02:24 ET | 1399 | 0.76905 |
02:26 ET | 411 | 0.76875 |
02:27 ET | 100 | 0.7687 |
02:31 ET | 100 | 0.76835 |
02:33 ET | 100 | 0.76835 |
02:40 ET | 7748 | 0.7657 |
02:42 ET | 200 | 0.7657 |
02:44 ET | 513 | 0.7658 |
02:45 ET | 200 | 0.76575 |
02:47 ET | 100 | 0.76575 |
02:49 ET | 100 | 0.76575 |
02:51 ET | 100 | 0.76575 |
02:54 ET | 100 | 0.76575 |
03:02 ET | 502 | 0.7651 |
03:03 ET | 200 | 0.7651 |
03:07 ET | 700 | 0.7627 |
03:09 ET | 500 | 0.7626 |
03:12 ET | 300 | 0.7629 |
03:14 ET | 100 | 0.7601 |
03:16 ET | 200 | 0.7601 |
03:18 ET | 459 | 0.7601 |
03:20 ET | 100 | 0.7601 |
03:21 ET | 100 | 0.7601 |
03:23 ET | 200 | 0.7601 |
03:25 ET | 664 | 0.7601 |
03:27 ET | 400 | 0.7601 |
03:30 ET | 300 | 0.7601 |
03:32 ET | 1787 | 0.7663 |
03:34 ET | 200 | 0.76345 |
03:36 ET | 100 | 0.76345 |
03:39 ET | 1100 | 0.7601 |
03:41 ET | 200 | 0.7601 |
03:43 ET | 300 | 0.7601 |
03:45 ET | 300 | 0.7601 |
03:48 ET | 400 | 0.7601 |
03:50 ET | 400 | 0.7601 |
03:52 ET | 808 | 0.7618 |
03:54 ET | 200 | 0.7601 |
03:56 ET | 1849 | 0.7618 |
03:57 ET | 1400 | 0.76 |
03:59 ET | 6563 | 0.76 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Eyenovia Inc | 41.5M | -1.0x | --- |
Vyne Therapeutics Inc | 34.6M | -0.4x | --- |
Lexaria Bioscience Corp | 49.1M | -4.8x | --- |
Cyclo Therapeutics Inc | 36.3M | -1.2x | --- |
Acasti Pharma Inc | 27.9M | -0.6x | --- |
Aptorum Group Ltd | 26.5M | -4.8x | --- |
Eyenovia, Inc. is a commercial-stage ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics based on its Optejet platform. It is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $41.5M |
---|---|
Revenue (TTM) | $8.8K |
Shares Outstanding | 53.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.82 |
EPS | $-0.74 |
Book Value | $0.20 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 4,724.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -344,127.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.